Case Study BByDonald B. Hunninghake, MD,MyNgoc A. Dang, PharmD,Larry Goodnight, RPh,Dean Inami, PharmD,Sheryl Sun, MD,Mohan Vodoor, RPhDecember 1st 1996
Case Study CByRobert Jacobs, MD,Tom J. Davies, JD, MPA,Cindy Giambrone, PharmD,Lionel Graveline, RPh,Robert Jastrzab, RPh,Daniel H. Lewis, RPh, MBADecember 1st 1996
Case Study DByDavid Rutledge, PharmD,Chad Green, PharmD,Jennifer Mason, RN,Ramie Ramirez, RPh,Dan Steiber, RPh,Alan Wright, MD, MPHDecember 1st 1996
Introduction: Creating an Optimal Strategy for Lipid ManagementByJames M. McKenney, PharmD,William H. Frishman, MDDecember 1st 1996
Recent Clinical Trials and Aggressive Management of Dyslipidemic PatientsByDonald B. Hunninghake, MDDecember 1st 1996
Epidemiologic Studies of Diet and Drug Therapy to Reach Target LDL-C LevelsByErza A. Amsterdam, MDDecember 1st 1996
Case Study AByAnne C. Goldberg, MD,Herb Bobo, RPh,Ken Kellick, PharmD,Andrew Szczotka, PharmDDecember 1st 1996
Dialogue: Recent Clinical Trials and Aggressive Management of Dyslipidemic PatientsByDecember 1st 1996
Dialogue: Epidemiologic Studies of Diet and Drug Therapy to Reach Target LDL-C LevelsByDecember 1st 1996
